Good pipeline, global presence and moving in the right direction
Inconvénients
Still feels like a young company, needs processes to establish and experience to gain.
Découvrez plus d’avis sur BeOne
5,0
24 avr. 2026
Employé (anonyme)
Employé (actuel)
Recommande
Approbation du PDG
Perspective commerciale
Avantages
BeOne Medicines is building a strong reputation as a global oncology-focused company with a patient-centered approach. They’ve demonstrated the ability to advance innovative therapies across both hematologic malignancies and solid tumors, while also expanding their global footprint in clinical development. Their collaborative culture and emphasis on scientific rigor make them a compelling organization to work with and learn from.
Inconvénients
Fast timelines and global expansion may translate into heavy workload and urgency